Analysts weigh in on Moderna's big drop following cancer vaccine results
Analysts weigh in on Moderna's big drop following cancer vaccine results Seeking Alpha
Covered in this story
What has happened since
- Moderna is up 0.0% since this was published.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Moderna
- Citi: $193 → $80 by Sep 2027 · Sell via 247wallst.com
- Rothschild & Co Redburn: $149 → $81 by Sep 2027 · Sell via Investing.com
- Morgan Stanley: $174 → $89 by Aug 2027 · Equalweight via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $MRNA yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Moderna →Dalsna Finance is currently tracking 16 stories mentioning Moderna, the earliest published 4 Oct 2026.
Summary aggregated from Seeking Alpha's public RSS feed. The full reporting belongs to Seeking Alpha — please read it on their site.